Immune Checkpoint Inhibitors and the Heart

Immune checkpoint inhibitors (ICIs) represent a break-through treatment for a large number of cancer types. This treatment is increasingly being recommended. ICIs are prescribed for primary tumours and for metastases, adjuvant/neo-adjuvant therapy. Thus, there is an increased need for expertise in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mocan-Hognogi, Diana Larisa, Trancǎ, Sebastian, Farcaş, Anca Daniela, Mocan-Hognogi, Radu Florin, Pârvu, Andrada Viorica, Bojan, Anca Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511816/
https://www.ncbi.nlm.nih.gov/pubmed/34660728
http://dx.doi.org/10.3389/fcvm.2021.726426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511816/
https://www.ncbi.nlm.nih.gov/pubmed/34660728
http://dx.doi.org/10.3389/fcvm.2021.726426

Ejemplares similares